Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
134M
-
Shares change
-
-1.01M
-
Total reported value, excl. options
-
$2.29B
-
Value change
-
-$7.29M
-
Put/Call ratio
-
1.14
-
Number of buys
-
101
-
Number of sells
-
-78
-
Price
-
$17.18
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q3 2016
216 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2016.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 134M shares
.
Largest 10 shareholders include OppenheimerFunds, Inc. (25M shares), PRIMECAP MANAGEMENT CO/CA/ (20M shares), VANGUARD GROUP INC (11.6M shares), BlackRock Fund Advisors (11M shares), Invesco Ltd. (4.35M shares), RA CAPITAL MANAGEMENT, LLC (3.66M shares), BlackRock Institutional Trust Company, N.A. (3.35M shares), STATE STREET CORP (3.33M shares), CAMBER CAPITAL MANAGEMENT LLC (3.2M shares), and BRIDGER MANAGEMENT, LLC (2.83M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.